Aveanna Healthcare Holdings, Inc. revenue
Aveanna Healthcare Holdings, Inc.'s revenue was $2.43bn in fiscal 2025, up 20.2% on the year before. Since fiscal 2019 ($1.38bn) it has grown at a compound 9.9% a year. Over the last twelve months it was $2.60bn.
Revenue history
| Fiscal year | 2019Dec 2019 | 2020Jan 2021 | 2021Jan 2022 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Jan 2026 | LTMJul 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1,384 | 1,495 | 1,679 | 1,788 | 1,895 | 2,025 | 2,433 | 2,603 |
| Growth on the year before | — | +8.0% | +12.3% | +6.5% | +6.0% | +6.8% | +20.2% | — |
| Gross profit | 419 | 455 | 542 | 553 | 595 | 636 | 810 | 840 |
| Gross margin | 30.3% | 30.4% | 32.3% | 30.9% | 31.4% | 31.4% | 33.3% | 32.3% |
Where the revenue comes from
| Line of business | Revenue | Share | YoY |
|---|---|---|---|
| Private Duty Services | $2B | 82.2% | ▲ 22.4% |
| Home Health and Hospice | $249M | 10.2% | ▲ 14.1% |
| Medical Solutions | $183M | 7.5% | ▲ 6.6% |
From Aveanna Healthcare Holdings, Inc.'s 10-K filed March 19, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.
Revenue against peers
| Company | Revenue | Growth | 3-year growth a year |
|---|---|---|---|
| Aveanna Healthcare Holdings, Inc. | $2.60bn | 19.5% | 12.4% |
| Hims & Hers Health, Inc. | $2.58bn | 28.0% | 53.7% |
| Chemed Corp | $2.66bn | 5.2% | 6.1% |
| Privia Health Group, Inc. | $2.36bn | 24.1% | 16.1% |
| Radnet, Inc. | $2.27bn | 18.9% | 14.1% |
| Evolent Health, Inc. | $2.10bn | -4.5% | 8.7% |
Compare with peers
- Hims & Hers Health, Inc. revenue
- Chemed Corp revenue
- Privia Health Group, Inc. revenue
- Radnet, Inc. revenue
- Evolent Health, Inc. revenue
Head to head: AVAH vs HIMSAVAH vs CHEAVAH vs PRVA
More: Health Care Services stocks compared, Health Care sector, rankings of US companies